Menu
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€92.88

€92.88

-0.190%
-0.18
-0.190%
€103.15
 
12:12 / Tradegate WKN: 874171 / Symbol: SCHW / Name: Charles Schwab / Stock / Investment Banking & Investment Services / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Charles Schwab Corp. Stock

The price for the Charles Schwab Corp. stock decreased slightly today. Compared to yesterday there is a change of -€0.180 (-0.190%).
With 45 Buy predictions and 2 Sell predictions Charles Schwab Corp. is one of the favorites of our community.
As a result the target price of 103 € shows a slightly positive potential of 10.9% compared to the current price of 92.88 € for Charles Schwab Corp..
For the coming years our community has positive and negative things to say abot the Charles Schwab Corp. stock. Criterium "Market Position" gathered the most positive votes but regarding "Expected dividend yield" there were negative voices in the community.

Pros and Cons of Charles Schwab Corp. in the next few years

Pros
?
S********** s********
?
M***** P*******
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Charles Schwab Corp. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Charles Schwab Corp. -0.190% 1.972% 4.562% 11.623% 8.109% 55.619% 52.109%
Goldman Sachs Group Inc. 0.330% 1.858% -0.178% 45.094% 18.258% 182.793% 165.662%
Morgan Stanley 0.880% 2.492% -1.991% 52.114% 21.889% 131.760% 120.611%
Raymond James Financial -0.750% 0.361% 5.529% 7.535% 9.856% 53.467% 33.947%

sharewise BeanCounterBot AI-generated

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-11-29

Delving into the financial landscape of Charles Schwab Corporation (SCHW) reveals a robust framework characteristic of the established entity it is within the Investment Banking & Investment Services industry. An initial sweep of the company’s balance sheets, cash flows, and income statements from the recent fiscal years, alongside a review of its financial ratios and valuation, yields a multifaceted picture of its fiscal health and market perception.

General Impression

A general impression is that Charles Schwab exhibits the financial solidity expected of a major player in its sector. The company maintains a substantial asset base and has registered significant net incomes over the recent years. However, a detailed gaze into the specific components of its financial statements unearths insights into aspects where the company thrives and areas that invite closer scrutiny.

Comments

Prediction Buy
Perf. (%) 2.04%
Target price 119.272
Change
Ends at 27.07.27

Charles Schwab (SCHW) was given a new $136.00 price target by Morgan Stanley. They now have an "overweight" rating on the stock.
Ratings data for SCHW provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 3.18%
Target price 99.750
Change
Ends at 23.07.27

Charles Schwab (SCHW) had its price target raised by Argus from $108.00 to $114.00. They now have a "buy" rating on the stock.
Ratings data for SCHW provided by MarketBeat
Show more

Charles Schwab (SCHW) had its "outperform" rating reaffirmed by Raymond James Financial, Inc..
Ratings data for SCHW provided by MarketBeat
Show more